/
OUR COMPANY Sylvamo Corporation (the Company or Sylvamo , which may also be referred to as we or us ) is a global uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills located in and serving the most attractive geographies, including Europe, Latin America and North America, which are our business segments. We produce uncoated freesheet ( UFS ) f…
$38.34
$1.22 (-3.08%)
EOD Jul 17, 2026
Operating margin is thin at 7.49%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 11.2% YoY. Margins deteriorated 4.5pp alongside, both lines moving the wrong way.
Free cash flow declined 82% versus the prior year, cash generation momentum has weakened. ROIC dropped from 19.07% to 10.36%, capital efficiency is deteriorating.
15.3x earnings, 151.8x FCF. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$3.29B
▼ -11.2% YoY
Net Income (TTM)
$102M
▼ -56.3% YoY
Op. Margin
5.84%
▼ -4.5pp YoY
ROIC
7.30%
▼ -8.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$10M
▼ -82.3% YoY
Op. Cash Flow (TTM)
$235M
▼ -42.9% YoY
Net Debt
$658M
Cash & Equiv.
$206M
5Y CAGR: +7.0%
5Y CAGR: -31.6%
Continue Research
At a P/E of 15.3 and a price-to-free-cash-flow of 151.8, Sylvamo (SLVM) trades above a two-stage DCF intrinsic value of about $-12.24 per share, so at $38.34 the stock looks overvalued (131.9% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Sylvamo scores 25/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 4.8%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $-12.24 per share for SLVM, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $-9.18. At today's $38.34, that puts the stock about 131.9% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Sylvamo scores 25 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 5.8% operating margin and a 7.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Sylvamo pays a regular dividend of about $1.84 per share per year (typically in quarterly installments), a yield of roughly 4.8% at the current price. That is a payout ratio of about 71.6% of earnings, so the dividend is covered, with less cushion. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For SLVM's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. SLVM currently trades above its estimated intrinsic value and scores 25/100 on quality (lower-quality). It also yields about 4.8%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.